HYRNUO
Analogs of HYRNUO
Find cheaper analogs and generic equivalents for HYRNUO.
Active Ingredient: SEVABERTINIB
Product Overview
About HYRNUO
HYRNUO is a prescription medication containing the active ingredient Sevabertinib. It is used to treat certain types of cancer, specifically non-small cell lung cancer (NSCLC) with a specific genetic mutation.
Key Benefits & Uses
- Treatment of non-small cell lung cancer (NSCLC) with a specific genetic mutation
- Targeted therapy to inhibit the growth and spread of cancer cells
- May be used in combination with other cancer treatments to improve outcomes
Active Ingredient & Action
Sevabertinib is a tyrosine kinase inhibitor that works by blocking the activity of a specific enzyme involved in the growth and spread of cancer cells. By inhibiting this enzyme, Sevabertinib helps to slow or stop the growth of cancer cells, which can help to control the progression of the disease.
Important Notes
HYRNUO is a prescription medication and should only be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosage and usage instructions carefully to minimize the risk of side effects. Patients taking HYRNUO should also inform their healthcare provider about any other medications they are taking, as well as any medical conditions they may have.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.